Glenmark Pharma share price rises on final USFDA approval for a generic

Glenmark Pharma has been granted final approval by the USFDA for Dimethyl Fumarate Delayed-Release Capsules.

Read Full Story on MoneyControl

Enter your email address:


We will be happy to hear your thoughts

      Leave a reply

      IndiaClicking - Buzzing News & Stocks